Company · Mississauga, Ontario, Canada
Cipher Pharmaceuticals Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 13
- 11 authorized now
- Natural health products
- 4
- 4 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 20
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ACTIKERALL | 02428946 | Marketed | |
| AGGRASTAT | 02240706 | Marketed | |
| BRINAVESS | 02462400 | Marketed | |
| DURELA | 02373017 | Marketed | |
| DURELA | 02373025 | Marketed | |
| DURELA | 02373033 | Marketed | |
| EPURIS | 02396971 | Marketed | |
| EPURIS | 02396998 | Marketed | |
| EPURIS | 02397005 | Marketed | |
| EPURIS | 02397013 | Marketed | |
| VANIQA | 02243837 | Marketed | |
| FENOMAX | 02249995 | Cancelled Pre Market | |
| FENOMAX | 02250004 | Cancelled Post Market |
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| Dexiderm Scalp | 80073497 | Active | |
| Dexiderm CD | 80072257 | Active | |
| Dexiderm SD | 80068209 | Active | |
| Dexiderm AD | 80068190 | Active |
Notices of Compliance
Newest first.
- EPURISMay 15, 2025 · NOC 35348 · Supplement to a New Drug Submission (SNDS)
- VANIQANovember 19, 2024 · NOC 34404 · Supplement to a New Drug Submission (SNDS)
- EPURISSeptember 20, 2024 · NOC 34052 · Supplement to a New Drug Submission (SNDS)
- EPURISMay 3, 2023 · NOC 30637 · Supplement to a New Drug Submission (SNDS)
- DURELAMarch 31, 2022 · NOC 27860 · Supplement to a New Drug Submission (SNDS)
- EPURISAugust 26, 2020 · NOC 24110 · Supplement to a New Drug Submission (SNDS)
- TRULANCEOctober 10, 2019 · NOC 22769 · New Drug Submission (NDS)
- VANIQASeptember 30, 2019 · NOC 22733 · Supplement to a New Drug Submission (SNDS)
- XYDALBASeptember 4, 2018 · NOC 21279 · New Drug Submission (NDS)
- BRINAVESSJuly 24, 2018 · NOC 21133 · New Drug Submission (NDS)
- AGGRASTATJuly 24, 2018 · NOC 21134 · New Drug Submission (NDS)
- SITAVIGNovember 27, 2017 · NOC 20091 · New Drug Submission (NDS)
- EPURISApril 1, 2016 · NOC 17950 · Supplement to a New Drug Submission (SNDS)
- BETEFLAMDecember 4, 2015 · NOC 17540 · New Drug Submission (NDS)
- ACTIKERALLAugust 28, 2015 · NOC 17235 · New Drug Submission (NDS)
- VANIQAJuly 22, 2015 · NOC 17120 · New Drug Submission (NDS)
- EPURISNovember 19, 2012 · NOC 13857 · New Drug Submission (NDS)
- DURELAAugust 30, 2011 · NOC 12610 · New Drug Submission (NDS)
- FENOMAXJuly 27, 2006 · NOC 8178 · Supplement to an Abbreviated New Drug Submission (SANDS)
- FENOFIBRATEFebruary 20, 2006 · NOC 7776 · Abbreviated New Drug Submission (ANDS)